Work

Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors

Year: 2024

Type: article

Source: Journal of Thrombosis and Thrombolysis

DOI: 10.1007/s11239-024-03054-2

Authors: Anthony Dumas, Navneet Goyal, Madhusoodanan Mottamal, Daniel K. Afosah, Rami A. Al-Horani

Institutions: Xavier University of Louisiana, Virginia Commonwealth University

Language: English

Topic: Coagulation, Bradykinin, Polyphosphates, and Angioedema

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute on Minority Health and Health Disparities

Awards: Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis, Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis, The RCMI Center for Cancer and Health Disparities Research, Inhibitors of Human Factor XIIIa as New Anticoagulants

OpenAlex ID: W4403970947

FWCI: 0.561

Cites: 53

Cited by: 2

Related to: 10